- Home
- BDX
as 10-29-2025 4:00pm EST
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
| Founded: | 1897 | Country: | United States |
| Employees: | N/A | City: | FRANKLIN LAKES |
| Market Cap: | 49.0B | IPO Year: | 1962 |
| Target Price: | $212.88 | AVG Volume (30 days): | 1.6M |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.47 | EPS Growth: | 12.91 |
| 52 Week Low/High: | $163.33 - $251.99 | Next Earning Date: | 11-06-2025 |
| Revenue: | $21,386,000,000 | Revenue Growth: | 7.86% |
| Revenue Growth (this year): | 9.4% | Revenue Growth (next year): | 4.29% |
Stock Insider Trading Activity of Becton Dickinson and Company (BDX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Feld Michael | BDX | EVP & President, Life Sciences | Oct 27 '25 | Sell | $186.01 | 57 | $10,602.57 | 8,245 | |
| Feld Michael | BDX | EVP & President, Life Sciences | Sep 26 '25 | Sell | $181.03 | 58 | $10,499.74 | 8,245 | |
| Fraser Claire | BDX | Director | Sep 10 '25 | Sell | $187.50 | 917 | $171,937.50 | 22,226 | |
| Feld Michael | BDX | EVP & President, Life Sciences | Aug 22 '25 | Sell | $197.99 | 57 | $11,285.43 | 8,245 | |
| HAYES GREGORY | BDX | N/A | Aug 11 '25 | Buy | $191.57 | 5,250 | $1,005,742.50 | 6,046 |
Latest Becton Dickinson and Company News
BDX Breaking Stock News: Dive into BDX Ticker-Specific Updates for Smart Investing
Simply Wall St.
5 days ago
Is There Now an Opportunity in BD After 18% Share Price Drop in 2025?
Simply Wall St.
5 days ago
Becton Dickinson (BDX): Evaluating Valuation After Recent Stretch of Quiet Trading
Zacks
5 days ago
Pharma, Specialty Units Likely to Drive Cardinal Health's Q1 Earnings
StockStory
6 days ago
1 Cash-Producing Stock with Exciting Potential and 2 We Turn Down
Zacks
6 days ago
Here's Why Becton Dickinson (BDX) is a Strong Growth Stock
Barchart
7 days ago
Here's What to Expect From Becton, Dickinson & Company’s Next Earnings Report
Insider Monkey
7 days ago
What Makes Becton Dickinson & Co. (BDX) a Good Investment?
PR Newswire
8 days ago
BD Simplifies At-Home HPV Testing to Broaden Access to Cervical Cancer Screening Outside United States
Compare BDX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BDX Becton Dickinson and Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.